| HOME >> BIOLOGY >> TECHNOLOGY |
Immunoassay and
Molecular Diagnostics 366.2 301.6 21.4% 16.8%
Total Clinical
Diagnostics 1,290.8 1,093.3 18.1% 13.7%
Life Sciences 238.0 210.1 13.3% 8.1%
Total revenue $1,528.8 $1,303.3 17.3% 12.8%
Note: Amounts may not foot due to rounding.
* Constant currency growth as presented herein represents:
Current period constant currency revenue less prior year reported revenue
Prior year reported revenue
Clinical Diagnostics
Chemistry and Clinical Automation includes:
> Autochemistry
> Protein and rapid test products
> Clinical Automation
Cellular includes:
> Hematology
> Coagulation
> Flow cytometry and related products
Immunoassay and Molecular Diagnositcs includes:
> All immunoassay products
> Molecular diagnostics products
Life Sciences
Life Sciences includes:
> Life science tools: (All robotic automation, genetic analysis
products, centrifuge and analytical systems)
> Industrial particle characterization
BECKMAN COULTER, INC
REVENUE BY SEGMENT
(in millions)
(unaudited)
2007
Qtr 1 Qtr 2 Qtr 3 Qtr 4 YTD
Clinical
Diagnostics
Chemistry and
Clinical
Automation $183.9 $205.0 $196.5 $229.9 $815.3
Cellular 194.4 208.3 203.0 235.2 840.9
Immunoassay and
Molecular
Diagnostics 141.9 159.7
'/>"/>
| SOURCE Beckman Coulter, Inc. Copyright©2008 PR Newswire. All rights reserved |